NYSE:ACAArcosa Stock Price, Forecast & News

Arcosa's stock was trading at $37.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACA shares have increased by 15.0% and is now trading at $42.60. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Arcosa.

Arcosa is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Arcosa.

Arcosa Inc (NYSE:ACA) released its quarterly earnings results on Tuesday, April, 28th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.20. The firm had revenue of $488.20 million for the quarter, compared to analysts' expectations of $479.22 million. Arcosa had a return on equity of 6.78% and a net margin of 6.46%. Arcosa's quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.58 EPS. View Arcosa's earnings history.

Arcosa announced a quarterly dividend on Tuesday, May 5th. Shareholders of record on Wednesday, July 15th will be paid a dividend of $0.05 per share on Friday, July 31st. This represents a $0.20 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Tuesday, July 14th. View Arcosa's dividend history.

4 equities research analysts have issued 12-month price objectives for Arcosa's stock. Their forecasts range from $48.00 to $56.00. On average, they anticipate Arcosa's stock price to reach $51.00 in the next twelve months. This suggests a possible upside of 19.7% from the stock's current price. View analysts' price targets for Arcosa.

Press coverage about ACA stock has been trending somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Arcosa earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutArcosa.

Arcosa saw a increase in short interest in April. As of April 30th, there was short interest totaling 861,300 shares, an increase of 7.0% from the April 15th total of 804,900 shares. Based on an average trading volume of 354,500 shares, the short-interest ratio is currently 2.4 days. Approximately 1.8% of the company's shares are short sold. View Arcosa's Current Options Chain.

Some companies that are related to Arcosa include Deere & Company (DE), AGCO (AGCO), Alamo Group (ALG), Lindsay (LNN) and Arts-Way Manufacturing (ARTW). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include Walt Disney (DIS), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Trinity Industries (TRN), Netflix (NFLX), Xilinx (XLNX), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.17%), State Street Corp (3.44%), Capital International Investors (2.10%), Thrivent Financial for Lutherans (1.87%), Franklin Resources Inc. (1.74%) and Loomis Sayles & Co. L P (1.45%). Company insiders that own Arcosa stock include Antonio Carrillo, Ronald J Gafford and Valueact Capital Master Fund,. View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Deutsche Bank AG, WINTON GROUP Ltd, Russell Investments Group Ltd., CNH Partners LLC, BlackRock Inc., Driehaus Capital Management LLC, and Morgan Stanley. Company insiders that have sold Arcosa company stock in the last year include Ronald J Gafford, and Valueact Capital Master Fund,. View insider buying and selling activity for Arcosa.

ACA stock was bought by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Silvercrest Asset Management Group LLC, JPMorgan Chase & Co., State Street Corp, Capital International Investors, Grantham Mayo Van Otterloo & Co. LLC, Mackay Shields LLC, and Cramer Rosenthal Mcglynn LLC. View insider buying and selling activity for Arcosa.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACA stock can currently be purchased for approximately $42.60.

Arcosa has a market capitalization of $2.05 billion and generates $1.74 billion in revenue each year. The company earns $113.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Arcosa employs 6,275 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at 972-942-6500 or via email at [email protected]